Literature DB >> 11268945

Differing effects of two nitric oxide synthase inhibitors on experimental colitis.

T Yamaguchi1, N Yoshida, E Ichiishi, N Sugimoto, Y Naito, T Yoshikawa.   

Abstract

BACKGROUND/AIMS: The aim of this study was to investigate the effects of two inhibitors of nitric oxide synthase on a rat model of colitis.
METHODOLOGY: Colitis was induced by administration of an enema containing trinitrobenzene sulfonic acid. This colitis was treated everyday for one week with NG-nitro-L-arginine (10 mg/kg, i.v.), which is a non-selective inhibitor of both constitutive nitric oxide synthase and inducible nitric oxide synthase, or aminoguanidine (10 mg/kg, i.v.) which is an inhibitor of inducible nitric oxide synthase. Exposure to the trinitrobenzene sulfonic acid enema inhibited the increase in body weight of rats, and markedly increased the colonic damage scores, wet weight, thiobarbituric acid-reactive substances and myeloperoxidase activity.
RESULTS: The inhibition of weight increase caused by trinitrobenzene sulfonic acid was significantly reduced by aminoguanidine treatment, whereas weight loss tended to be aggravated by NG-nitro-L-arginine treatment. The increases in the colonic damage scores, wet weight, thiobarbituric acid-reactive substances and myeloperoxidase activity in trinitrobenzene sulfonic acid-colitis were significantly inhibited by aminoguanidine treatment, although they tended to be aggravated by NG-nitro-L-arginine treatment.
CONCLUSIONS: These results suggest that an inhibitor of inducible nitric oxide synthase, but not of constitutive nitric oxide synthase, was effective in treating experimental colitis in rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11268945

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Role of blood- and tissue-associated inducible nitric-oxide synthase in colonic inflammation.

Authors:  Christian F Krieglstein; Christoph Anthoni; Wolfgang H Cerwinka; Karen Y Stokes; Janice Russell; Matthew B Grisham; D Neil Granger
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 2.  Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle.

Authors:  George Kolios; Vassilis Valatas; Stephen G Ward
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

Review 3.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

4.  Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis.

Authors:  Bindu Chandrasekharan; Vanitha Bala; Vasantha L Kolachala; Matam Vijay-Kumar; Dean Jones; Andrew T Gewirtz; Shanthi V Sitaraman; Shanthi Srinivasan
Journal:  PLoS One       Date:  2008-10-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.